HPS Pharmacies wish to advise that both suppliers are experiencing a supply interruption for capecitabine 500mg tablets as follows:
Xelabine
Capecitabine 500mg
ARTG 213045
Capecitabine Sandoz
Capecitabine 500mg
ARTG 201800
This supply interruption is expected to be resolved by the end of July 2025.
An internationally registered alternative has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. This product is registered in the US and all labelling is in English.
Please note that S19A products may have a longer lead time as they must be sourced internationally.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
This notice only applies to the 500mg presentation. Capecitabine 150mg tablets are currently available.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates
